Empirical Modeling for Glucose Control in Critical Care and Diabetes

Empirical Volterra series models of glucose–insulin behavior were identified from input–output data provided by a physiologically-based nonlinear patient model. While completely identified nonlinear Volterra models provided accurate output prediction, clinical data limitations constrained the structure of the Volterra series to linear plus nonlinear diagonal coefficients. In the absence of measurement noise, the ability of this structurally constrained model to capture process dynamics was very good. The addition of Gaussian distributed measurement noise, having variance 10 mg2/dL2, significantly degraded coefficient estimates, but projection onto the Laguerre basis (with subsequent expansion to the Volterra space for analysis) provided excellent noise-filtering and model predictions requiring only 164 measurements to identify 121 Volterra coefficients. Linear and nonlinear model predictive control algorithms were developed from the identified Volterra models. In the absence of measurement noise, nonlinear control algorithms provided mild performance enhancement in rejecting a 50 g glucose challenge. With the addition of measurement noise matching the above noise characteristics, the benefits of nonlinear control were lost. The superiority of the nonlinear empirical model to capture open-loop data did not translate into closed-loop performance enhancement in the presence of measurement noise. Linear model predictive control, with the ability to filter noise effects by proper tuning, provided the best combination of performance and robustness to uncertainty (both measurement and model) in this nonlinear case study.

[1]  Wei Jiang,et al.  On-line outlier detection and data cleaning , 2004, Comput. Chem. Eng..

[2]  Francis J. Doyle,et al.  The identification of nonlinear models for process control using tailored “plant-friendly” input sequences , 2001 .

[3]  Robert D. Nowak,et al.  Random and pseudorandom inputs for Volterra filter identification , 1994, IEEE Trans. Signal Process..

[4]  J. Jaremko,et al.  Advances Toward the Implantable Artificial Pancreas for Treatment of Diabetes , 1998, Diabetes Care.

[5]  Robert S. Parker,et al.  A NONLINEAR DATA-DRIVEN APPROACH TO TYPE I DIABETIC PATIENT MODELING , 2002 .

[6]  Francis J. Doyle,et al.  Glucose control design using nonlinearity assessment techniques , 2005 .

[7]  E. Zafiriou,et al.  Output Constraint Softening for SISO Model Predictive Control , 1993, 1993 American Control Conference.

[8]  Miet Schetz,et al.  Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* , 2003, Critical care medicine.

[9]  J. Radziuk,et al.  An adaptive plasma glucose controller based on a nonlinear insulin/glucose model , 1994, IEEE Transactions on Biomedical Engineering.

[10]  G. Steil,et al.  Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis. , 2003, Diabetes technology & therapeutics.

[11]  M. Schetzen The Volterra and Wiener Theories of Nonlinear Systems , 1980 .

[12]  H. Kaufman,et al.  Multiple-model adaptive predictive control of mean arterial pressure and cardiac output , 1992, IEEE Transactions on Biomedical Engineering.

[13]  M. Fisher,et al.  A semiclosed-loop algorithm for the control of blood glucose levels in diabetics , 1991, IEEE Transactions on Biomedical Engineering.

[14]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[15]  R.S. Parker,et al.  A model-based algorithm for blood glucose control in Type I diabetic patients , 1999, IEEE Transactions on Biomedical Engineering.

[16]  Ronald K. Pearson,et al.  Nonlinear model-based control using second-order Volterra models , 1995, Autom..

[17]  Julie L. Eiseman,et al.  Toward Model-Based Chemotherapy Treatment Design , 2004 .

[18]  R. Wolfe,et al.  Glucose metabolism in man: responses to intravenous glucose infusion. , 1979, Metabolism: clinical and experimental.

[19]  W. Schenk,et al.  Does Physiological Blood Glucose Control Require an Adaptive Control Strategy? , 1987, IEEE Transactions on Biomedical Engineering.

[20]  W Kerner,et al.  Implantable glucose sensors: present status and future developments. , 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[21]  G Albrecht,et al.  Estimation of individually adapted control parameters for an artificial beta cell. , 1984, Biomedica biochimica acta.

[22]  R. Wolfe,et al.  Effect of severe burn injury on substrate cycling by glucose and fatty acids. , 1987, The New England journal of medicine.

[23]  Evanghelos Zafiriou,et al.  Robust process control , 1987 .

[24]  Robert S. Parker,et al.  Advanced model predictive control (MPC) for type I diabetic patient blood glucose control , 2000, Proceedings of the 2000 American Control Conference. ACC (IEEE Cat. No.00CH36334).

[25]  R. Wolfe,et al.  Differentiation between septic and postburn insulin resistance. , 1989, Metabolism: clinical and experimental.

[26]  R. Bellazzi,et al.  The subcutaneous route to insulin-dependent diabetes therapy. , 2001, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.

[27]  B.W. Bequette,et al.  Model predictive control of blood glucose in type I diabetics using subcutaneous glucose measurements , 2002, Proceedings of the 2002 American Control Conference (IEEE Cat. No.CH37301).

[28]  W. Rugh Nonlinear System Theory: The Volterra / Wiener Approach , 1981 .

[29]  G. Steil,et al.  Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. , 2003, Diabetes technology & therapeutics.

[30]  R. Potts,et al.  Glucose monitoring by reverse iontophoresis , 2002, Diabetes/metabolism research and reviews.

[31]  H Wedel,et al.  Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .

[32]  Timothy W. Evans,et al.  Glucose Control and Mortality in Critically Ill Patients , 2003 .

[33]  B. Wayne Bequette,et al.  Simultaneous Regulation of Hemodynamic and Anesthetic States: A Simulation Study , 2004, Annals of Biomedical Engineering.

[34]  Francis J. Doyle,et al.  Optimal control of a continuous bioreactor using an empirical nonlinear model , 2001 .

[35]  R. Busch,et al.  Accuracy of home blood glucose monitors using forearm blood samples: FreeStyle versus One Touch Ultra. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[36]  Francis J. Doyle,et al.  Robust H∞ glucose control in diabetes using a physiological model , 2000 .

[37]  David Q. Mayne,et al.  Constrained model predictive control: Stability and optimality , 2000, Autom..

[38]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[39]  Gabriele Pannocchia,et al.  A Fast, Easily Tuned, SISO, Model Predictive Controller , 2004 .

[40]  R S Parker,et al.  The intravenous route to blood glucose control. , 2001, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.

[41]  G. Grunkemeier,et al.  Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.

[42]  R S Parker,et al.  Control-relevant modeling in drug delivery. , 2001, Advanced drug delivery reviews.

[43]  G. Dumont,et al.  An optimum time scale for discrete Laguerre network , 1993, IEEE Trans. Autom. Control..

[44]  Alberto Maran,et al.  Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. , 2002, Diabetes care.

[45]  Robert S. Parker,et al.  Glucose Control in Type I Diabetic Patients: A Volterra Model-Based Approach , 2004 .

[46]  John Thomas Sorensen,et al.  A physiologic model of glucose metabolism in man and its use to design and assess improved insulin therapies for diabetes , 1985 .

[47]  R. Ollerton Application of optimal control theory to diabetes mellitus , 1989 .

[48]  E. Zafiriou,et al.  Nonlinear system identification for control using Volterra-Laguerre expansion , 1995, Proceedings of 1995 American Control Conference - ACC'95.

[49]  Francis J. Doyle,et al.  Nonlinear model predictive control of a continuous bioreactor at near-optimum conditions , 1998, Proceedings of the 1998 American Control Conference. ACC (IEEE Cat. No.98CH36207).

[50]  Sirish L. Shah,et al.  Long-range predictive control with a terminal matching condition , 1994 .

[51]  D.S. Ward,et al.  Open loop control of multiple drug effects in anesthesia , 1995, IEEE Transactions on Biomedical Engineering.

[52]  A Caduff,et al.  First human experiments with a novel non-invasive, non-optical continuous glucose monitoring system. , 2003, Biosensors & bioelectronics.

[53]  D. Kerr,et al.  Making ‘sense’ of diabetes: using a continuous glucose sensor in clinical practice , 2002, Diabetes/metabolism research and reviews.

[54]  Ronald K. Pearson,et al.  Identification of structurally constrained second-order Volterra models , 1996, IEEE Trans. Signal Process..

[55]  Manfred Morari,et al.  Model predictive control: Theory and practice - A survey , 1989, Autom..

[56]  E D Lehmann,et al.  A physiological model of glucose-insulin interaction in type 1 diabetes mellitus. , 1992, Journal of biomedical engineering.